Work

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(10)62312-4

Authors: Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve, Hein Putter, Annette Hasenburg, Jean-Michel Vannetzel, Robert Paridaens, Christos Markopoulos, Yasuo Hozumi, Elysee TM Hille, Dirk G Kieback, Lina Asmar, Jan Smeets, Johan WR Nortier, Peyman Hadji, John MS Bartlett, Stephen E Jones

Institutions: Leiden University, Leiden University Medical Center, University of Birmingham, Erasmus MC Cancer Institute, University Medical Center Freiburg, Universitair Ziekenhuis Leuven, KU Leuven, National and Kapodistrian University of Athens, Jichi Medical University, Elblandklinikum Riesa, Pfizer (United States), Philipps University of Marburg, University of Edinburgh

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2139023087

FWCI: 15.18

Cites: 33

Cited by: 374

Related to: 10